Back to mobile site

Xenon Pharmaceuticals (XENE) joins Russell 2000 and 3000

June 27, 2025 4:02 PM EDT Send to a Friend
Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to discovering, developing, and delivering life-changing therapeutics for patients in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login